dc.date.accessioned2022-01-18T19:35:51Z
dc.date.available2022-01-18T19:35:51Z
dc.date.created2022-01-18T19:35:51Z
dc.date.issued2012
dc.identifierhttps://hdl.handle.net/20.500.12866/11215
dc.identifierhttps://doi.org/10.4269/ajtmh.2012.10-0565
dc.description.abstractPyrazinamidase of Mycobacterium tuberculosis catalyzes the conversion of pyrazinamide to the active molecule pyrazinoic acid. Reduction of pyrazinamidase activity results in a level of pyrazinamide resistance. Previous studies have suggested that pyrazinamidase has a metal-binding site and that a divalent metal cofactor is required for activity. To determine the effect of divalent metals on the pyrazinamidase, the recombinant wild-type pyrazinamidase corresponding to the H37Rv pyrazinamide-susceptible reference strain was expressed in Escherichia coli with and without a carboxy terminal. His-tagged pyrazinamidase was inactivated by metal depletion and reactivated by titration with divalent metals. Although Co2+, Mn2+, and Zn2+ restored pyrazinamidase activity, only Co2+ enhanced the enzymatic activity to levels higher than the wild-type pyrazinamidase. Cu2+, Fe 2+, Fe3+, and Mg2+ did not restore the activity under the conditions tested. Various recombinant mutated pyrazinamidases with appropriate folding but different enzymatic activities showed a differential pattern of recovered activity. X-ray fluorescence and atomic absorbance spectroscopy showed that recombinant wild-type pyrazinamidase expressed in E. coli most likely contained Zn. In conclusion, this study suggests that M. tuberculosis pyrazinamidase is a metalloenzyme that is able to coordinate several ions, but in vivo, it is more likely to coordinate Zn2+. However, in vitro, the metal-depleted enzyme could be reactivated by several divalent metals with higher efficiency than Zn.
dc.languageeng
dc.publisherAmerican Society of Tropical Medicine and Hygiene
dc.relationAmerican Journal of Tropical Medicine and Hygiene
dc.relation1476-1645
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectControlled study
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectnon protein expression
dc.subjectunclassified drug
dc.subjectMycobacterium tuberculosis
dc.subjectKinetics
dc.subjectpyrazinamide
dc.subjectAmidohydrolases
dc.subjectatomic absorption spectrometry
dc.subjectbacterial enzyme
dc.subjectcarboxy terminal sequence
dc.subjectCircular Dichroism
dc.subjectcobalt
dc.subjectdivalent cation
dc.subjectenzyme activity
dc.subjectenzyme inactivation
dc.subjectenzyme reactivation
dc.subjectEscherichia coli
dc.subjectferric ion
dc.subjectferrous ion
dc.subjectmagnesium ion
dc.subjectmanganese
dc.subjectmetal ion
dc.subjectMetals
dc.subjectModels, Molecular
dc.subjectpyrazinamidase
dc.subjectrecombinant enzyme
dc.subjectSpectrophotometry, Atomic
dc.subjecttitrimetry
dc.subjectwild type
dc.subjectX ray fluorescence
dc.subjectzinc ion
dc.titleRole of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución